Review
Published on 15 Apr 2021
Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.645558
- 7,259 views
- 16 citations




